Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

BR-931

Known as: BR 931 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1992
1992
Immunohistochemical staining of enoyl CoA hydratase (ECH), a key peroxisomal enzyme, revealed that the putative preneoplastic… Expand
Is this relevant?
1991
1991
Previous studies have demonstrated that BR-931, a hepatic peroxisome proliferator, can induce liver tumours in mice and rats… Expand
  • figure 1
  • table I
  • table II
  • figure 2
Is this relevant?
1989
1989
Hypolipidemic drugs and certain plasticizers markedly increase the number of peroxisomes in liver parenchymal cells. Continued… Expand
Is this relevant?
1986
1986
The potent peroxisome proliferator hepatocarcinogens WY-14,643, BR-931, and nafenopin, as well as mono(ethylhexyl)phthalate (MEHP… Expand
Is this relevant?
1984
1984
The peroxisome proliferators Wy-14,643, BR-931, nafenopin and ciprofibrate were tested in the primary hepatocyte culture… Expand
Is this relevant?
1982
1982
1 The effects of hypolipidemic drugs fenofibrate (isopropyl[4-(p-chlorobenzoyl)-2-phenoxy-2-methyl]propionate), pyrinixil (BR-931… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
1981
1981
The hypolipidaemic drugs methyl clofenapate, BR-931, Wy-14643 and procetofen induced a marked proliferation of peroxisomes in the… Expand
Is this relevant?
Highly Cited
1980
Highly Cited
1980
Several drugs, including clofibrate (ethyl-a-p-chlorophenoxyisobutyrate)1, are now available for the treatment of… Expand
Is this relevant?
1978
1978
Administration of BR-931, an ethanolamine derivative of Wy-14,643 [4-chloro-6-(2,3-xylidino)-2-pyrimidinythio]acetic acid, at a… Expand
Is this relevant?
1978
1978
BR-931 [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio-(N-beta-hydroxyethyl)-acetamide], a new hypolipidemic agent of low toxicity… Expand
Is this relevant?